Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growthin vitroandin vivo

Authors:

Abstract
Oncotarget | https://doi.org/10.18632/oncotarget.25421 Shuhei Shinoda, Seiji Kaino, Shogo Amano, Hirofumi Harima, Toshihiko Matsumoto, Koichi Fujisawa, Taro Takami, Naoki Yamamoto, Takahiro Yamasaki, Isao Sakaida Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo

This publication has 31 references indexed in Scilit: